Childhood cancers: open trials in Japan

49 open trials have a site in Japan. Registry data; only the trial team decides who can take part.

NCT05384626
A Study of Neladalkib (NVL-655) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ALK Rearrangement or Activating ALK Mutation (ALKOVE-1)
Trial Treatment · Phase 1/2 · Nuvalent Inc.
Kanagawa Cancer Center, Kanagawa · Okayama University Hospital, Okayama · Kindai University Hospital, Osaka · Shizuoka Cancer Center, Shizuoka · Cancer Institute Hospital of JFCR, Tokyo · National Cancer Center Hospital, Tokyo · Wakayama Medical University Hospital, Wakayama
Registry updated 2026-11-06
NCT05862285
A Rollover Study for Participants Previously Enrolled in a Genentech and/or F. Hoffman-La Roche Sponsored Study
Trial Treatment · Phase 3 · Hoffmann-La Roche
National Cancer Center Hospital East, Chiba · National Hospital Organization Kyushu Medical Center, Chuo-ku, Fukuoka-shi · Kyushu University Hospital, Fukuoka · Kanagawa Cancer Center, Kanagawa · Yokohama City University Medical Center, Kanagawa · Toranomon Branch Hospital, Kanagawa · National Cancer Center Hospital East, Kashiwa-shi · National Hospital Organization Shikoku Cancer Center, Matsuyama · Iwate Medical University Hospital, Numakunai · Saitama Cancer Center, Saitama · NHO Kinki-Chuo Chest Medical Center, Sakaishi
Registry updated 2026-11-06
NCT07378969
A Non-Interventional Study PASS to Characterize Secondary Malignancies of Tcell Origin Following Tisagenlecleucel Therapy
Research · Novartis Pharmaceuticals
Bunkyo Ku · Kurume · Osaka · Suita
Registry updated 2026-11-06
NCT04811560
A Phase 1/2 Study of Bleximenib in Participants With Acute Leukemia (cAMeLot-1)
Trial Treatment · Phase 1/2 · Janssen Research & Development, LLC
Kyushu University Hospital, Fukuoka · Fukushima Medical University Hospital, Fukushima · Kanazawa University Hospital, Kanazawa · National Cancer Center Hospital East, Kashiwa · Kobe City Medical Center General Hospital, Kobe · Gunmaken Saiseikai Maebashi Hospital, Maebashi · Nagoya University Hospital, Nagoya · Hokkaido University Hospital, Sapporo · NTT Medical Center Tokyo, Tokyo · Yamagata University Hospital, Yamagata · University of Fukui Hospital, Yoshida
Registry updated 2026-11-04
NCT03340506
Dabrafenib and/or Trametinib Rollover Study
Trial Treatment · Phase 4 · Novartis Pharmaceuticals
Chuo Ku · Kashiwa
Registry updated 2026-11-03
NCT04924075
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
National Cancer Center Hospital (Site 1802), Chuo-ku · Kyoto University Hospital (Site 1806), Kyoto · Kochi Medical School Hospital (Site 1807), Nankoku · Hokkaido University Hospital (Site 1800), Sapporo · Tokyo Women's Medical University Adachi Medical Center (Site 1803), Tokyo · Yokohama City University Hospital (Site 1804), Yokohama
Registry updated 2026-11-03
NCT03435796
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Trial Treatment · Phase 2/3 · Celgene
Bunkyō City · Chiba University Hospital, Chiba · National Cancer Center Hospital, Chuo Ku · Kyushu University Hospital, Fukuoka · Tokai University Hospital, Isehara City, Kanagawa · University Hospital Kyoto Prefectural University of Medicine, Kyoto · Toranomon Hospital, Minato-ku · Nagoya City University Hospital, Nagoya · National Hospital Organization Okayama Medical Center, Okayama · Osaka Metropolitan University Hospital, Osaka · Hokkaido University Hospital, Sapporo · Japan Red Cross Medical Center, Shibuya-ku · Jichi Medical University Hospital, Shimotsuke · Shinjuku · Osaka Red Cross Hospital, Tennoji-Ku · Yamagata University Hospital, Yamagata
Registry updated 2026-11-02
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Tokyo Metropolitan Komagome Hospital (Site 2106), Bunkyo · Toranomon Hospital (Site 2101), Minato
Registry updated 2026-10-30
NCT07155226
Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Kashiwa · Okayama
Registry updated 2026-10-23
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Chiba University Hospital, Chiba · Ehime University Hospital, Ehime · Hiroshima University Hospital, Hiroshima · Hokkaido University Hospital, Hokkaido · Hyogo Prefectural Kobe Childrens Hospital, Hyōgo · Kagoshima University Hospital, Kagoshima · Kanagawa Childrens Medical Center, Kanagawa · Kyoto Prefectural University of Medicine, Kyoto · Kyoto University Hospital, Kyoto · Mie University Hospital, Mie · Nagoya University Graduate School of Medicine, Nagoya · Osaka University Graduate School of Medicine 2-2, Osaka · Osaka City General Hospital, Osaka · Saitama Prefectural Childrens Medical Center, Saitama · Shizuoka Childrens Hospital, Shizuoka · Tohoku University Hospital, Tōhoku · National Center for Child Health and Development, Tokyo · The University of Tokyo Hospital, Tokyo · Nippon Medical School Hospital, Tokyo · Tokyo Metropolitan Childre's Medical Center, Tokyo
Registry updated 2026-10-19
NCT07109219
Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Chūōku · Kashiwa
Registry updated 2026-10-15
NCT07354074
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Trial Treatment · Phase 2 · Novartis Pharmaceuticals
Fukuoka · Saitama · Yokohama
Registry updated 2026-10-15
NCT04566380
ONO-4538 Phase II Rollover Study (ONO-4538-98)
Trial Treatment · Phase 2 · Ono Pharmaceutical Co., Ltd.
Akashi · Bunkyo-ku · Chiba · Chuo-ku · Fukuoka · Fukuoka · Hidaka · Hiroshima · Kashiwa · Kitaadachi-gun · Koto-ku · Koto-Ku · Kurume · Kyoto · Matsuyama · Okayama · Osaka · Sapporo · Shinjuku-ku · Suita · Takatsuki · Yokohama · Yufu
Registry updated 2026-10-14
NCT06137118
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Chiba · Chūōku · Fukuoka · Kashiwa · Kyoto · Okayama · Osaka · Sapporo · Toyohashi · Yamagata
Registry updated 2026-10-13
NCT06137144
AZD3470 as Monotherapy or in Combination With Anticancer Agent(s) in Participants With Haematologic Malignancies.
Trial Treatment · Phase 1/2 · AstraZeneca
Bunkyō City · Kōtoku
Registry updated 2026-10-13
NCT07734116
A Study of ONO-4538HSC in Pediatric Patients With Malignant Solid Tumors and in Patients With Epithelioid Sarcoma.
Trial Treatment · Phase 1/2 · Ono Pharmaceutical Co., Ltd.
Chiba University Hospital, Chiba · National Cancer Center Hospital, Chuo Ku · Kyushu University Hospital, Fukuoka · Hiroshima University Hospital, Hiroshima · Kanazawa University Hospital, Kanazawa · National Cancer Center Hospital East, Kashiwa · Kyoto University Hospital, Kyoto · Okayama University Hospital, Okayama · Osaka International Cancer Institute, Osaka · Kindai University Hospital, Sakai · Hokkaido University Hospital, Sapporo · Tohoku University Hospital, Sendai · Shizuoka Cancer Center, Sunto-gun · Mie University Hospital, Tsu · Yokohama City University Hospital, Yokohama
Registry updated 2026-10-06
NCT07602777
A Study Evaluating the Efficacy and Safety of Risvutatug Rezetecan in Participants With Advanced Sarcomas (EMBOLD Sarcoma-202)
Trial Treatment · Phase 1/2 · GlaxoSmithKline
Fukuoka · Hokkaido · Tokyo
Registry updated 2026-10-01
NCT06079671
Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)
Trial Treatment · Phase 3 · AstraZeneca
Fukuoka · Ginowan-shi · Hidaka-shi · Kagoshima · Kōtoku · Kurume-shi · Maebashi · Matsuyama · Morioka · Nagoya · Osaka · Sapporo · Shinjuku-ku · Suita-shi · Sunto-gun · Toon-Shi
Registry updated 2026-09-30
NCT04925479
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Osaka · Shinjuku Ku · Yokohama
Registry updated 2026-09-25
NCT05118789
A Study of Zidesamtinib (NVL-520) in Patients With Advanced NSCLC and Other Solid Tumors Harboring ROS1 Rearrangement (ARROS-1)
Trial Treatment · Phase 1/2 · Nuvalent Inc.
Kanagawa Cancer Center, Kanagawa · Okayama University Hospital, Okayama · Kindai University Hospital, Osaka · Shizuoka Cancer Center, Shizuoka · The Cancer Institute Hospital of JFCR, Tokyo · National Cancer Center Hospital, Tokyo · Wakayama Medical University Hospital, Wakayama
Registry updated 2026-09-24
NCT05041309
Long-Term Follow-Up Study After Gene-Modified Cell Treatment in Kite Studies
Research · Phase 2 · Kite, A Gilead Company
Kyushu University Hospital, Fukuoka · Kyoto University Hospital, Kyoto · Okayama University Hospital, Okayama · Hokkaido University Hospital, Sapporo Hokkaido · Tohoku University Hospital, Sendai · National Cancer Center Hospital, Tokyo
Registry updated 2026-09-21
NCT07819526
Acute Ischemic Stroke in Patients With Active Cancer
Research · Osaka University
The Univeristy of Osaka, Suita
Registry updated 2026-09-21
NCT04094311
Study of Out of Specification for Tisagenlecleucel
Trial Treatment · Phase 3 · Novartis Pharmaceuticals
Aomori · Bunkyo Ku · Chiba · Chuo Ku · Fuchū · Fukuoka · Gifu · Hamamatsu · Hiroshima · Ishikawa · Izumi · Izumisano · Izumo · Kita-gun · Kobe · Kumamoto · Kurashiki · Kyoto · Matsumoto · Minato Ku · Nagasaki · Nagoya · Niigata · Nishinomiya · Okayama · Osaka · Saitama · Sakai · Sapporo · Sendai · Setagaya-ku · Shinjuku Ku · Suita · Tōon · Tsu · Tsukuba · Wakayama · Yokohama · Yufu
Registry updated 2026-09-15
NCT03067181
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
Trial Treatment · Phase 3 · Children's Oncology Group
Chiba University, Chiba-sgi · Saitama Children's Medical Center, Chuo-ku · Kyushu Univeristy, Higashiku · Hiroshima University Hospital, Hiroshima · Hyogo Prefectural Kobe Children's Hospital, Kobe · Kyoto Perfectural University of Medicine, Kyoto · Niigata Cancer Centre, Niigata · Hyogo College of Medicine, Nishinomiya, Hyogo · Osaka City General Hospital, Osaka · Saitama Medical University International Medical Center, Saitama · Hokkaido University Hospital, Sapporo · Tohoku University School of Medicine, Sendai · Keio University, Shinjuku-ku · National Cancer Center Hospital, Tokyo · Kokuritsu Seiiku Medical Research Center Hospital, Tokyo · University of Tsukuba Hospital, Tsukuba · Kanagawa Children's Medical Center, Yokohama
Registry updated 2026-08-25
NCT07196644
A Study to Assess Adverse Events and Change in Disease Activity in Participants 12 Years of Age or Older With Locally Advanced or Metastatic Solid Tumors That Harbor MET Amplification Receiving Intravenously Infused Telisotuzumab Adizutecan
Trial Treatment · Phase 2 · AbbVie
National Cancer Center Hospital /ID# 276297, Chuo-Ku · Kyushu University Hospital /ID# 276302, Fukuoka · National Cancer Center Hospital East /ID# 276298, Kashiwa-shi · Kyoto University Hospital /ID# 276398, Kyoto · Nagoya University Hospital /ID# 276336, Nagoya · Okayama University Hospital /ID# 276299, Okayama · Hokkaido University Hospital /ID# 276333, Sapporo · Tohoku University Hospital /ID# 276344, Sendai
Registry updated 2026-08-14

All Childhood cancers trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error